Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly | Lima | Healthcare | Pharmaceuticals | PEN 2.71T | 69.8x | 0.72 | PEN 3,181.94 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Johnson & Johnson | Lima | Healthcare | Pharmaceuticals | PEN 1.44T | 27.9x | -0.49 | PEN 606.43 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AbbVie | Lima | Healthcare | Pharmaceuticals | PEN 1.38T | 88.8x | -7.36 | PEN 692.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck | Lima | Healthcare | Pharmaceuticals | PEN 865.07B | 13.8x | 0 | PEN 351.64 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amgen | Lima | Healthcare | Pharmaceuticals | PEN 615.86B | 41.2x | -1.08 | PEN 967.92 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pfizer | Lima | Healthcare | Pharmaceuticals | PEN 534.72B | 18.1x | 0.07 | PEN 96.15 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gilead Sciences | Lima | Healthcare | Pharmaceuticals | PEN 521.25B | 297.3x | -3.33 | PEN 403 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bristol Myers Squibb | Lima | Healthcare | Pharmaceuticals | PEN 445.37B | -13.6x | 0.06 | PEN 204.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |